ArticleFrontiers in oncology2026
Case Report: Clinicopathological features and outcomes of superficial cervicovaginal myofibroblastoma: analysis of two cases and a review of the literature.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Superficial cervicovaginal myofibroblastoma (SCVM) is a benign mesenchymal tumor that arises from the superficial stromal layer of the submucosal vagina and cervix in females. This tumor is clinically rare, occurs most frequently in women aged 20-60 years, and is often difficult to distinguish from other soft tissue tumors of the female genital tract due to overlapping clinical and pathological features. Case description: Two cases of SCVM located in the vagina of female patients were reported. One patient presented with vaginal bleeding, whereas the other lesion was identified during a routine physical examination in the absence of obvious clinical symptoms. Both patients underwent surgical resection of the tumor. The final diagnosis of SCVM was established through an integrated evaluation of histopathological morphology, immunohistochemical profiles, and molecular pathology findings. During follow-up periods ranging from 6 months to 1 year, no tumor recurrence or additional clinical symptoms were observed. Conclusion: A review of the English-language literature identified a total of 78 reported cases of SCVM, and their clinical manifestations, pathological features, and treatment outcomes were summarized. The findings indicate that SCVM occurs predominantly in women of reproductive age, demonstrates slow growth and benign biological behavior, exhibits hormone-related characteristics, and is associated with a favorable prognosis following surgical excision, with recurrence being extremely rare. Accurate diagnosis depends on the combined assessment of morphological features and immunohistochemical findings to reliably differentiate SCVM from other mesenchymal tumors of the cervix and vagina.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.